Skip to main content

Behavioral Medicine Treatments for Heart Failure

  • Reference work entry
  • First Online:
Handbook of Cardiovascular Behavioral Medicine

Abstract

Heart failure (HF) is a major public health concern affecting millions of people worldwide, with rates dramatically increasing as the population ages. HF is often the end stage of various cardiovascular disorders that result in myocardial hypertrophy and leading to the ultimate failure of the left ventricle. Behavioral and psychosocial risk factors that contribute to cardiovascular diseases can subsequently contribute to HF as an outcome. Behavioral risk factors for HF include a sedentary lifestyle, poor medication adherence, inadequate dietary habits resulting in suboptimal control of glucose levels or obesity, and abuse of alcohol or stimulants. Depression is common in HF and associated with poor prognosis and mortality. An often-neglected feature of the treatment of HF involves lifestyle changes and improved adherence to medications. Telehealth can be an important intervention that can reduce HF hospitalizations by educating patients about diet modifications (e.g., sodium and fluid restriction) and regular weight monitoring and by directing changes in diuretics and other medications. Exercise is beneficial in maintaining overall functional capacity in HF. Interventions that have both psychosocial benefits and physical activity benefits such as yoga and tai chi may be valuable for reducing depression, increasing physical function, and ultimately improving quality of life in patients with HF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 549.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ades P, Wu G (2004) Benefits of tai chi in chronic heart failure: body or mind? Am J Med Sci 117(8):611–612

    Google Scholar 

  2. Albert N, Fonarow G, Abraham W, Gheorghiade M, Greenberg B, Nunez E, O’Connor C, Stough W, Yancy C, Young J (2009) Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med 122(4):366–373

    Article  PubMed  Google Scholar 

  3. Antman E, Tanasijevic M, Thompson B, Schactman M, McCabe C, Cannon C, Fischer G, Fung A, Thompson C, Wybenga D, Braunwald E (1996) Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335(18):1342–1349

    Article  PubMed  Google Scholar 

  4. Appel L, Champagne C, Harsha D, Cooper L, Obarzanek E, Elmer P, Stevens V, Vollmer W, Lin P, Svetkey L, Stedman S, Young D (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289(16):2083–2093

    PubMed  Google Scholar 

  5. Araujo JP, Lourenco P, Azevedo A, Frioes F, Rocha-Goncalves F, Ferreira A, Bettencourt P (2009) Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 15(3):256–266

    Article  PubMed  Google Scholar 

  6. Ard J, Coffman C, Lin P, Svetkey L (2004) One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants. Am J Hypertens 17(12 Pt 1):1156–1162

    Article  PubMed  Google Scholar 

  7. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD, Investigators C (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25):3173–3180

    Article  PubMed  Google Scholar 

  8. Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty A, Malik R (2009) Diabetic cardiomyopathy. Clin Sci (London, Engl) 116(10):741–760

    Article  Google Scholar 

  9. Audette J, Jin YS, Newcomer R, Stein L, Duncan G, Frontera WR (2006) Tai Chi versus brisk walking in elderly women. Age Ageing 35(4):388–393

    Article  PubMed  Google Scholar 

  10. Baliga R (2007) Applying hypertension guidelines to reduce the burden of heart failure. Cardiol Clin 25(4):507–522

    Article  PubMed  Google Scholar 

  11. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, Martinez-Alonso M, Carmona C, Barcelo A et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307(20):2161–2168. https://doi.org/10.1001/jama.2012.4366

    Article  PubMed  Google Scholar 

  12. Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty S, Clapp-Channing N, Davidson-Ray L, Fraulo E, Fishbein D, Luceri R, Ip J (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237

    Article  PubMed  Google Scholar 

  13. Celis R, Torre-Martinez G, Torre-Amione G (2008) Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol 23(3):254–260

    Article  PubMed  Google Scholar 

  14. Chen J, Fujimoto C, Vistica BP, He J, Wawrousek EF, Kelsall B, Gery I (2006) Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J Immunol 177(5):3362–3368

    Article  PubMed  Google Scholar 

  15. Cheng T (2006) Tai Chi for chronic heart failure. Int J Cardiol 110(1):96

    Article  PubMed  Google Scholar 

  16. Chida Y, Steptoe A (2008) Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med 70(7):741–756

    Article  PubMed  Google Scholar 

  17. Chiuve S, McCullough M, Sacks F, Rimm E (2006) Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 114(2):160–167

    Article  PubMed  Google Scholar 

  18. Chiuve SE, Cook NR, Shay CM, Rexrode KM, Albert CM, Manson JE, Willett WC, Rimm EB (2014) Lifestyle-based prediction model for the prevention of CVD: the Healthy Heart Score. J Am Heart Assoc 3(6):e000954. https://doi.org/10.1161/JAHA.114.000954

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, American Heart Association Clinical Pharmacology Committee of the Council on Clinical C, Council on Basic Cardiovascular S, Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiopulmonary CCP, Resuscitation, Council on E, Prevention, Council on Functional G, Translational B, Council on Quality of C, Outcomes R et al (2017) Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement From the American Heart Association. Circulation 135(22):e1054–e1091

    Article  PubMed  Google Scholar 

  20. Clerico A, Vittorini S, Passino C, Emdin M (2009) New and emerging biomarkers of heart failure. Crit Rev Clin Lab Sci 46(3):107–128

    Article  PubMed  Google Scholar 

  21. Coats A (2005) Advances in the non-drug, non-surgical, non-device management of chronic heart failure. Int J Cardiol 100(1):1–4

    Article  PubMed  Google Scholar 

  22. Cohen-Solal A, Beauvais F, Logeart D (2008) Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J Card Fail 14(7):615–625

    Article  PubMed  Google Scholar 

  23. Colin-Ramirez E, McAlister FA, Zheng Y, Sharma S, Armstrong PW, Ezekowitz JA (2015) The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study. Am Heart J 169(2):274–281, e271. https://doi.org/10.1016/j.ahj.2014.11.013

  24. Conraads VM, Jorens PG, De Clerck LS, Van Saene HK, Ieven MM, Bosmans JM, Schuerwegh A, Bridts CH, Wuyts F, Stevens WJ, Anker SD, Rauchhaus M, Vrints CJ (2004) Selective intestinal decontamination in advanced chronic heart failure: a pilot trial. Eur J Heart Fail 6(4):483–491

    Article  PubMed  Google Scholar 

  25. Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R, Kao A, Khayat RN, Oldenburg O, Stellbrink C, Abraham WT, remede System Pivotal Trial Study G (2016) Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet 388(10048):974–982

    Article  PubMed  Google Scholar 

  26. Daniels LB, Clopton P, Jiang K, Greenberg B, Maisel AS (2010) Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels. J Card Fail 16(2):93–98

    Article  PubMed  Google Scholar 

  27. Davies M, Gibbs C, Lip G (2000) ABC of heart failure. BMJ 320(7230):297–300

    Article  PubMed  PubMed Central  Google Scholar 

  28. de Leon CF, Grady KL, Eaton C, Rucker-Whitaker C, Janssen I, Calvin J, Powell LH (2009) Quality of life in a diverse population of patients with heart failure: baseline findings from the heart failure adherence and retention trial (HART). J Cardiopulm Rehabil Prev 29(3):171–178

    Article  PubMed  Google Scholar 

  29. de Virginy D (2006) Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review. Heart Fail Rev 11(4):333–334

    Article  PubMed  Google Scholar 

  30. Diercks D, Fonarow G, Kirk J, Jois-Bilowich P, Hollander J, Weber J, Wynne J, Mills R, Yancy C, Peacock WT (2008) Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). Am J Cardiol 102(9):1216–1219

    Article  PubMed  Google Scholar 

  31. Dolliner P, Brammen L, Graf S, Huelsmann M, Stiebellehner L, Gleiss A, Ubl P, Steurer G (2013) Portable recording for detecting sleep disorder breathing in patients under the care of a heart failure clinic. Clin Res Cardiol 102(7):535–542

    Article  PubMed  Google Scholar 

  32. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1–e62

    Article  PubMed  Google Scholar 

  33. Fito M, Estruch R, Salas-Salvado J, Martinez-Gonzalez MA, Aros F, Investigators PS et al (2014) Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial. Eur J Heart Fail 16(5):543–550

    Article  PubMed  Google Scholar 

  34. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, Investigators O-H, Hospitals (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168(8):847–854

    Article  PubMed  Google Scholar 

  35. Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH (2015) Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med 175(11):1773–1782

    Article  PubMed  PubMed Central  Google Scholar 

  36. Friedmann E, Thomas SA, Inguito P, Kao CW, Metcalf M, Kelley FJ, Gottlieb SS (2006) Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol 17(1):65–72

    Article  PubMed  Google Scholar 

  37. Fuzhong L, McAuley E, Fisher KJ, Harmer P, Chaumeton N, Wilson NL (2002) Self-efficacy as a mediator between fear of falling and functional ability in the elderly. J Aging Health 14(4):452–466

    Article  PubMed  Google Scholar 

  38. Gerstein H, Miller M, Byington R, Goff DJ, Bigger J, Buse J, Cushman W, Genuth S, Ismail-Beigi F, Grimm RJ, Probstfield J, Simons-Morton D, Friedewald W (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545–2559

    Article  PubMed  Google Scholar 

  39. Giannuzzi P, Temporelli P, Marchioli R, Maggioni A, Balestroni G, Ceci V, Chieffo C, Gattone M, Griffo R, Schweiger C, Tavazzi L, Urbinati S, Valagussa F, Vanuzzo D (2008) Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 168(20):2194–2204

    Article  PubMed  Google Scholar 

  40. Gidron Y, Gilutz H, Berger R, Huleihel M (2002) Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res 56(1):15–21

    Article  PubMed  Google Scholar 

  41. Givens J, Datto CJ, Ruckdeschel K, Knott K, Zubritsky C, Oslin DW, Nyshadham S, Vanguri P, Barg FK (2006) Older patients’ aversion to antidepressants. A qualitative study. J Gen Intern Med 21(2):146–151

    PubMed  PubMed Central  Google Scholar 

  42. Good D, Morse S, Ventura H, Reisin E (2008) Obesity, hypertension, and the heart. J Cardiometab Syndr 3(3):168–172

    Article  PubMed  Google Scholar 

  43. Gottlieb SS, Kop WJ, Ellis SJ, Binkley P, Howlett J, O’Connor C, Blumenthal JA, Fletcher G, Swank AM, Cooper L (2009) Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol 103(9):1285–1289

    Article  PubMed  PubMed Central  Google Scholar 

  44. Grayburn P, Appleton C, DeMaria A, Greenberg B, Lowes B, Oh J, Plehn J, Rahko P, St John Sutton M, Eichhorn E (2005) Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 45(7):1064–1071

    Article  PubMed  Google Scholar 

  45. Greenberg BH (2002) Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials. J Card Fail 8(6 Suppl):S486–S490

    Article  PubMed  Google Scholar 

  46. Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM (2007) A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J Am Coll Cardiol 49(24):2329–2336

    Article  PubMed  Google Scholar 

  47. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, American Heart Association Advocacy Coordinating C, Stroke C, Council on Cardiovascular R, Intervention, Council on Clinical C, Council on E, Prevention, Council on A, Thrombosis, Vascular B, Council on C, Critical C, Perioperative, Resuscitation, Council on Cardiovascular N, Council on the Kidney in Cardiovascular D, Council on Cardiovascular S, Anesthesia, Interdisciplinary Council on Quality of C, Outcomes R et al (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123(8):933–944

    Article  PubMed  Google Scholar 

  48. Heo S, Lennie TA, Moser DK, Kennedy RL (2014) Types of social support and their relationships to physical and depressive symptoms and health-related quality of life in patients with heart failure. Heart Lung 43(4):299–305. https://doi.org/10.1016/j.hrtlng.2014.04.015

    Article  PubMed  Google Scholar 

  49. Hu X, Dai S, Wu W, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116(6):654–663

    Article  PubMed  PubMed Central  Google Scholar 

  50. Hummel SL, DeFranco AC, Skorcz S, Montoye CK, Koelling TM (2009) Recommendation of low-salt diet and short-term outcomes in heart failure with preserved systolic function. Am J Med 122(11):1029–1036. https://doi.org/10.1016/j.amjmed.2009.04.025

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hunt SA, American College of C, American Heart Association Task Force on Practice G (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46(6):e1–e82

    Article  PubMed  Google Scholar 

  52. Hwang B, Moser DK, Pelter MM, Nesbitt TS, Dracup K (2015) Changes in depressive symptoms and mortality in patients with heart failure: effects of cognitive-affective and somatic symptoms. Psychosom Med 77(7):798–807

    Article  PubMed  PubMed Central  Google Scholar 

  53. Iestra J, Knoops K, Kromhout D, de Groot L, Grobbee D, van Staveren W (2006) Lifestyle, Mediterranean diet and survival in European post-myocardial infarction patients. Eur J Cardiovasc Prev Rehabil 13(6):894–900

    Article  PubMed  Google Scholar 

  54. Investigators G (2005) Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ 331(7514):425

    Article  Google Scholar 

  55. Irwin M (2002) Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 16(1):1–16

    Article  PubMed  Google Scholar 

  56. Ismail H, McFarlane JR, Nojoumian AH, Dieberg G, Smart NA (2013) Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysis. JACC Heart Fail 1(6):514–522

    Article  PubMed  Google Scholar 

  57. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, Mohammed AA, Schlett CL, Nagurney JT, Hoffmann U, Koenig W (2010) High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 121(10):1227–1234

    Article  PubMed  PubMed Central  Google Scholar 

  58. Javaheri S (2017) Heart failure. In: Kryger M, Roth T, Dement WC (eds) Principles and practices of sleep medicine, 6th edn. Elsevier, Philadelphia, pp 1271–1285

    Chapter  Google Scholar 

  59. Jayadevappa R, Johnson J, Bloom B, Nidich S, Desai S, Chhatre S, Raziano D, Schneider R (2007) Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethn Dis 17(1):72–77

    PubMed  Google Scholar 

  60. Jónsdóttir S, Andersen K, Sigurosson A, Sigurosson S (2006) The effect of physical training in chronic heart failure. Eur J Heart Fail 8(1):97–101

    Article  PubMed  Google Scholar 

  61. Kakkar R, Lee RT (2008) The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7(10):827–840

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kalla A, Figueredo VM (2017) Alcohol and cardiovascular disease in the geriatric population. Clin Cardiol 40(7):444–449

    Article  PubMed  PubMed Central  Google Scholar 

  63. Kasai T, Narui K, Dohi T, Yanagisawa N, Ishiwata S, Ohno M, Yamaguchi T, Momomura S (2008) Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133(3):690–696

    Article  PubMed  Google Scholar 

  64. Kato M, Adachi T, Koshino Y, Somers V (2009) Obstructive sleep apnea and cardiovascular disease. Circ J 73(8):1363–1370

    Article  PubMed  Google Scholar 

  65. Kim ES, Smith J, Kubzansky LD (2014) Prospective study of the association between dispositional optimism and incident heart failure. Circ Heart Fail 7(3):394–400

    Article  PubMed  PubMed Central  Google Scholar 

  66. Knoops K, de Groot L, Kromhout D, Perrin A, Moreiras-Varela O, Menotti A, van Staveren W (2004) Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292(12):1433–1439

    Article  PubMed  Google Scholar 

  67. Komamura K, Shannon R, Ihara T, Shen Y, Mirsky I, Bishop S, Vatner S (1993) Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Phys 265(4 Pt 2):H1119–H1131

    Google Scholar 

  68. Lan C, Chen SY, Lai JS, Wong MK (2001) Heart rate responses and oxygen consumption during Tai Chi Chuan practice. Am J Chin Med 29(3–4):403–410

    Article  PubMed  Google Scholar 

  69. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22(4):370–379

    Article  PubMed  Google Scholar 

  70. Laonigro I, Correale M, Di Biase M, Altomare E (2009) Alcohol abuse and heart failure. Eur J Heart Fail 11(5):453–462

    Article  PubMed  Google Scholar 

  71. Lavie C, Milani R, Ventura H (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21):1925–1932

    Article  PubMed  Google Scholar 

  72. Lavretsky H, Kumar A (2002) Clinically significant non-major depression: old concepts, new insights. Am J Geriatr Psychiatry 10(3):239–255

    Article  PubMed  Google Scholar 

  73. Ledwidge M, Gallagher J, Conlon C, Tallon E, O’Connell E, Dawkins I et al (2013) Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA 310(1):66–74

    Article  PubMed  Google Scholar 

  74. Lee C, Burnett JJ (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12(2):131–142

    Article  PubMed  Google Scholar 

  75. Levy D, Larson M, Vasan R, Kannel W, Ho K (1996) The progression from hypertension to congestive heart failure. JAMA 275(20):1557–1562

    Article  PubMed  Google Scholar 

  76. Li J, Hong Y, Chan KM (2001) Tai Chi: physiological characteristics and beneficial effects on health. Br J Sports Med 35(3):148–156

    Article  PubMed  PubMed Central  Google Scholar 

  77. Lip G, Gibbs C, Beevers D (2000) ABC of heart failure: aetiology. BMJ 320(7227):104–107

    Article  PubMed  PubMed Central  Google Scholar 

  78. Lyness J, Heo M, Datto CJ, Ten Have TR, Katz IR, Drayer R, Reynolds CF 3rd, Alexopoulos GSBM (2006) Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 144(7):496–504

    Article  PubMed  Google Scholar 

  79. Maisel A, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161–167

    Article  PubMed  Google Scholar 

  80. Mansky P, Sannes T, Wallerstedt D, Ge A, Ryan M, Johnson L, Chesney M, Gerber L (2006) Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivors. Integr Cancer Ther 5(3):192–201

    Article  PubMed  Google Scholar 

  81. Marcinkiewicz A, Ostrowski S, Drzewoski J (2017) Can the onset of heart failure be delayed by treating diabetic cardiomyopathy? Diabetol Metab Syndr 9:21

    Article  PubMed  PubMed Central  Google Scholar 

  82. McAuley E, Morris KS, Motl RW, Hu L, Konopack JF, Elavsky S (2007) Long-term follow-up of physical activity behavior in older adults. Health Psychol 26(3):375–380

    Article  PubMed  Google Scholar 

  83. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Investigators S, Coordinators et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931

    Article  PubMed  Google Scholar 

  84. McKelvie RS (2008) Exercise training in patients with heart failure: clinical outcomes, safety, and indications. Heart Fail Rev 13(1):3–11

    Article  PubMed  Google Scholar 

  85. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Investigators P-H, Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004

    Article  PubMed  Google Scholar 

  86. Mielniczuk LM, Baughman KL (2006) Immune modulation therapy in heart failure. Congest Heart Fail 12(2):91–96

    Article  PubMed  Google Scholar 

  87. Mills PJ, Dimsdale JE, Natarajan L, Ziegler MG, Maisel A, Greenberg BH (2009) Sleep and health-related quality of life in heart failure. Congest Heart Fail 15(5):228–233

    Article  PubMed  PubMed Central  Google Scholar 

  88. Mills PJ, Redwine L, Wilson K, Pung MA, Chinh K, Greenberg BH, Lunde O, Maisel A, Raisinghani A, Wood A, Chopra D (2015) The role of gratitude in spiritual well-being in asymptomatic heart failure patients. Spirit Clin Pract 2(1):5–17

    Article  Google Scholar 

  89. Motivala S, Sollers J, Thayer J, Irwin MR (2006) Tai Chi Chih acutely decreases sympathetic nervous system activity in older adults. J Gerontol A Biol Sci Med Sci 61(11):1177–1180

    Article  PubMed  Google Scholar 

  90. Naughton M (2008) Common sleep problems in ICU: heart failure and sleep-disordered breathing syndromes. Crit Care Clin 24(3):565–587

    Article  PubMed  Google Scholar 

  91. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Investigators H-A et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14):1439–1450. https://doi.org/10.1001/jama.2009.454

    Article  PubMed  PubMed Central  Google Scholar 

  92. Oxman T, Sengupta A (2002) Treatment of minor depression. Am J Geriatr Psychiatry 10(3):256–264

    Article  PubMed  Google Scholar 

  93. Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Investigators P-H, Coordinators et al (2015) Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation 131(1):54–61

    Article  PubMed  Google Scholar 

  94. Pandey A, Parashar A, Kumbhani D, Agarwal S, Garg J, Kitzman D, Levine B, Drazner M, Berry J (2015) Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail 8(1):33–40

    Article  PubMed  Google Scholar 

  95. Pepys M, Hirschfield G (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805–1812

    Article  PubMed  PubMed Central  Google Scholar 

  96. Persson H, Lonn E, Edner M, Baruch L, Lang C, Morton J, Ostergren J, McKelvie R (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 49(6):687–694

    Article  PubMed  Google Scholar 

  97. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P et al (2009) BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301(4):383–392

    Article  PubMed  Google Scholar 

  98. Pischke C, Weidner G, Elliott-Eller M, Ornish D (2007) Lifestyle changes and clinical profile in coronary heart disease patients with an ejection fraction of <or=40% or >40% in the Multicenter Lifestyle Demonstration Project. Eur J Heart Fail 9(9):928–934

    Article  PubMed  Google Scholar 

  99. Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, Diaz G, Tunstead J, Logothetis DE, Hajjar RJ, Schecter AD (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41(5):834–844

    Article  PubMed  PubMed Central  Google Scholar 

  100. Quehenberger O (2005) Thematic review series: the immune system and atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis. J Lipid Res 46(8):1582–1590

    Article  PubMed  Google Scholar 

  101. Redwine L, Wirtz P, Hong S, Pandzic I, Cammarata S, Tafur J, Carter S, Greenberg B, Mills P (2009) A potential shift from adaptive immune activity to nonspecific inflammatory activation associated with higher depression symptoms in chronic heart failure patients. J Card Fail 15(7):607–615

    Article  PubMed  PubMed Central  Google Scholar 

  102. Redwine LS, Tsuang M, Rusiewicz A, Pandzic I, Cammarata S, Rutledge T, Hong S, Linke S, Mills PJ (2012) A pilot study exploring the effects of a 12-week t’ai chi intervention on somatic symptoms of depression in patients with heart failure. J Altern Complement Med 18(8):744–748

    Article  PubMed  PubMed Central  Google Scholar 

  103. Redwine LS, Hong S, Rutledge T, Wentworth B, Pung M, Ziegler MG, Maisel A, Greenberg B, Mills PJ (2014) Leukocyte ß-adrenergic receptor sensitivity and depression severity in patients with heart failure. Psychosom Med 76(9):726–731

    Article  PubMed  PubMed Central  Google Scholar 

  104. Redwine LS, Henry BL, Pung MA, Wilson K, Chinh K, Knight B, Jain S, Rutledge T, Greenberg B, Maisel A, Mills PJ (2016) Pilot randomized study of a gratitude journaling intervention on heart rate variability and inflammatory biomarkers in patients with stage B heart failure. Psychosom Med 78(6):667–676. https://doi.org/10.1097/PSY.0000000000000316

    Article  PubMed  PubMed Central  Google Scholar 

  105. Reinhardt D, Sigusch H, Hensse J, Tyagi S, Körfer R, Figulla H (2002) Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart 88(5):525–530

    Article  PubMed  PubMed Central  Google Scholar 

  106. Ren J, Wold L (2008) Mechanisms of alcoholic heart disease. Ther Adv Cardiovasc Dis 2(6):497–506

    Article  PubMed  Google Scholar 

  107. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K et al (2007) Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69–e171

    Article  PubMed  Google Scholar 

  108. Rozanski A, Blumenthal J, Davidson K, Saab P, Kubzansky L (2005) The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 45(5):637–651

    Article  PubMed  Google Scholar 

  109. Rudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54(3):227–240

    Article  PubMed  Google Scholar 

  110. Russo I, Frangogiannis NG (2016) Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities. J Mol Cell Cardiol 90:84–93

    Article  PubMed  Google Scholar 

  111. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48(8):1527–1537

    Article  PubMed  Google Scholar 

  112. Rutledge T, Redwine LS, Linke SE, Mills PJ (2013) A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med. https://doi.org/10.1097/PSY.0b013e318291d798

  113. Rutschow S, Li J, Schultheiss HP, Pauschinger M (2006) Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res 69(3):646–656

    Article  PubMed  Google Scholar 

  114. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O’Connor CM, Adams KF Jr, Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167(4):367–373

    Article  PubMed  Google Scholar 

  115. Shimbo D, Chaplin W, Crossman D, Haas D, Davidson KW (2005) Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol 96(7):1016–1021

    Article  PubMed  Google Scholar 

  116. Spinale FG, Zile MR (2013) Integrating the myocardial matrix into heart failure recognition and management. Circ Res 113(6):725–738

    Article  PubMed  Google Scholar 

  117. Stein JV, Nombela-Arrieta C (2005) Chemokine control of lymphocyte trafficking: a general overview. Immunology 116(1):1–12

    Article  PubMed  PubMed Central  Google Scholar 

  118. Stewart JC, Janicki DL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW (2007) Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiatry 64(2):225–233

    Article  PubMed  Google Scholar 

  119. Stratmann B, Tschoepe D (2008) Sweet heart – contributions of metabolism in the development of heart failure in diabetes mellitus. Exp Clin Endocrinol Diabetes 116(Suppl 1):S40–S45

    Article  PubMed  Google Scholar 

  120. Sullivan M, Wood L, Terry J, Brantley J, Charles A, McGee V, Johnson D, Krucoff M, Rosenberg B, Bosworth H, Adams K, Cuffe M (2009) The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 157(1):84–90

    Article  PubMed  Google Scholar 

  121. Szabo MC, Butcher EC, McIntyre BW, Schall TJ, Bacon KB (1997) RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 27:1061–1068

    Article  PubMed  Google Scholar 

  122. Torre-Amione G (2005) Immune activation in chronic heart failure. Am J Cardiol 95(11A):3C–8C; discussion 38C–40C

    Article  PubMed  Google Scholar 

  123. Tsuchihashi-Makaya M, Kato N, Chishaki A, Takeshita A, Tsutsui H (2009) Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J 73(2):280–287

    Article  PubMed  Google Scholar 

  124. Turley A, Raja S, Salhiyyah K, Nagarajan K (2008) Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Interact Cardiovasc Thorac Surg 7(6):1141–1146

    Article  PubMed  Google Scholar 

  125. van der Wal M, Jaarsma T (2008) Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 125(2):203–208

    Article  PubMed  Google Scholar 

  126. Waldman WJ, Williams MV Jr, Lemeshow S, Binkley P, Guttridge D, Kiecolt-Glaser JK, Knight DA, Ladner KJ, Glaser R (2008) Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav Immun 22(2):215–223

    Article  PubMed  Google Scholar 

  127. Watson K, Summers KM (2009) Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 29(1):49–63

    Article  PubMed  Google Scholar 

  128. Wexler R, Elton T, Pleister A, Feldman D (2009) You can do more to slow the progression of heart failure. J Fam Pract 58(3):122–128. jfp_5803a [pii]

    PubMed  Google Scholar 

  129. Whooley M, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney R, Ali S, Dowray S, Na B, Feldman M, Schiller N, Browner W (2008) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300(20):2379–2388

    Article  PubMed  PubMed Central  Google Scholar 

  130. Wirtz PH, Hong S, Redwine LS, Tafur J, Rutledge T, Ziegler MG, Greenberg B, Mills PJ (2009) Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure. Biol Psychiatry 65(9):801–807

    Article  PubMed  Google Scholar 

  131. Witham M, Daykin A, McMurdo M (2008) Pilot study of an exercise intervention suitable for older heart failure patients with left ventricular systolic dysfunction. Eur J Cardiovasc Nurs 7(4):303–306

    Article  PubMed  Google Scholar 

  132. Woodend A, Sherrard H, Fraser M, Stuewe L, Cheung T, Struthers C (2008) Telehome monitoring in patients with cardiac disease who are at high risk of readmission. Heart Lung 37(1):36–45

    Article  PubMed  Google Scholar 

  133. Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, American Heart Association Statistics C, Stroke Statistics S et al (2016) Executive summary: heart disease and stroke statistics – 2016 update: a report From the American Heart Association. Circulation 133(4):447–454

    Article  Google Scholar 

  134. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM et al (2017) 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. https://doi.org/10.1016/j.cardfail.2017.04.014

  135. Yeh GY, Wood MJ, Lorell BH, Stevenson LW, Eisenberg DM, Wayne PM, Goldberger AL, Davis RB, Phillips RS (2004) Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med 117(8):541–548

    Article  PubMed  Google Scholar 

  136. Yeh GY, Chan CW, Wayne PM, Conboy L (2016) The impact of Tai Chi exercise on self-efficacy, social support, and empowerment in heart failure: insights from a qualitative sub-study from a randomized controlled trial. PLoS One 11(5):e0154678

    Article  PubMed  PubMed Central  Google Scholar 

  137. Yeh GY, Wang C, Wayne PM, Phillips RS (2008) The effect of tai chi exercise on blood pressure: a systematic review. Prev Cardiol 11(2):82–89

    Google Scholar 

  138. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Group PRS et al (2008) Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 359(12):1225–1237

    Article  PubMed  PubMed Central  Google Scholar 

  139. Zile MR, Claggett BL, Prescott MF, McMurray JJ, Packer M, Rouleau JL, Swedberg K, Desai AS, Gong J, Shi VC, Solomon SD (2016) Prognostic implications of changes in N-Terminal Pro-B-type natriuretic peptide in patients with heart failure. J Am Coll Cardiol 68(22):2425–2436

    Article  PubMed  Google Scholar 

  140. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15(3):199–226

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura S. Redwine .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Redwine, L.S., Greenberg, B.H., Mills, P.J. (2022). Behavioral Medicine Treatments for Heart Failure. In: Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., Katzel, L.I. (eds) Handbook of Cardiovascular Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85960-6_49

Download citation

Publish with us

Policies and ethics